ATROPINE\DIPHENOXYLATE: 1,871 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
1,871
Total FAERS Reports
100 (5.3%)
Deaths Reported
450
Hospitalizations
1,871
As Primary/Secondary Suspect
15
Life-Threatening
15
Disabilities
Active Ingredient: ATROPINE SULFATE\DIPHENOXYLATE HYDROCHLORIDE ·
First Report: 1961 · Latest Report: 20250201
What Are the Most Common ATROPINE\DIPHENOXYLATE Side Effects?
#1 Most Reported
Drug ineffective
935 reports (50.0%)
#2 Most Reported
Macular degeneration
484 reports (25.9%)
#3 Most Reported
Product use issue
276 reports (14.8%)
All ATROPINE\DIPHENOXYLATE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 935 | 50.0% | 10 | 277 |
| Macular degeneration | 484 | 25.9% | 0 | 205 |
| Product use issue | 276 | 14.8% | 10 | 44 |
| Weight decreased | 270 | 14.4% | 3 | 227 |
| Nausea | 268 | 14.3% | 0 | 206 |
| Malaise | 262 | 14.0% | 0 | 204 |
| Constipation | 241 | 12.9% | 2 | 168 |
| Off label use | 235 | 12.6% | 2 | 193 |
| Pain | 226 | 12.1% | 1 | 204 |
| Diarrhoea | 218 | 11.7% | 12 | 72 |
| Pyrexia | 217 | 11.6% | 0 | 207 |
| Therapeutic product effect incomplete | 209 | 11.2% | 0 | 191 |
| Abdominal pain | 205 | 11.0% | 0 | 176 |
| Headache | 196 | 10.5% | 0 | 160 |
| Chronic sinusitis | 192 | 10.3% | 0 | 189 |
| Paraesthesia oral | 192 | 10.3% | 0 | 189 |
| Dyspepsia | 187 | 10.0% | 0 | 170 |
| Frequent bowel movements | 187 | 10.0% | 0 | 170 |
| Anaemia | 179 | 9.6% | 2 | 172 |
| Infusion related reaction | 178 | 9.5% | 0 | 175 |
Who Reports ATROPINE\DIPHENOXYLATE Side Effects? Age & Gender Data
Gender: 77.5% female, 22.5% male. Average age: 64.9 years. Most reports from: US. View detailed demographics →
Is ATROPINE\DIPHENOXYLATE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2001 | 1 | 0 | 1 |
| 2002 | 3 | 0 | 2 |
| 2004 | 3 | 0 | 1 |
| 2007 | 4 | 1 | 0 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 0 |
| 2010 | 1 | 0 | 1 |
| 2011 | 5 | 0 | 0 |
| 2012 | 7 | 2 | 4 |
| 2013 | 9 | 5 | 3 |
| 2014 | 25 | 0 | 4 |
| 2015 | 30 | 1 | 6 |
| 2016 | 44 | 3 | 12 |
| 2017 | 246 | 22 | 65 |
| 2018 | 21 | 1 | 12 |
| 2019 | 19 | 6 | 5 |
| 2020 | 17 | 0 | 2 |
| 2021 | 14 | 0 | 1 |
| 2022 | 13 | 0 | 3 |
| 2023 | 6 | 0 | 2 |
| 2024 | 12 | 0 | 2 |
| 2025 | 2 | 0 | 2 |
What Is ATROPINE\DIPHENOXYLATE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 629 |
| Diarrhoea | 588 |
| Irritable bowel syndrome | 70 |
| Colitis microscopic | 27 |
| Colitis ulcerative | 17 |
| Crohn's disease | 16 |
| Colitis | 11 |
| Abdominal discomfort | 6 |
| Bowel movement irregularity | 6 |
| Gastrointestinal disorder | 6 |
ATROPINE\DIPHENOXYLATE vs Alternatives: Which Is Safer?
ATROPINE\DIPHENOXYLATE vs AUBAGIO
ATROPINE\DIPHENOXYLATE vs AUGMENTIN
ATROPINE\DIPHENOXYLATE vs AUTOLOGOUS CULTURED CHONDROCYTES
ATROPINE\DIPHENOXYLATE vs AUTOLOGOUS CULTURED CHONDROCYTES\SUS SCROFA COLLAGEN
ATROPINE\DIPHENOXYLATE vs AVACINCAPTAD PEGOL
ATROPINE\DIPHENOXYLATE vs AVACOPAN
ATROPINE\DIPHENOXYLATE vs AVALGLUCOSIDASE ALFA-NGPT
ATROPINE\DIPHENOXYLATE vs AVANAFIL
ATROPINE\DIPHENOXYLATE vs AVANDAMET
ATROPINE\DIPHENOXYLATE vs AVANDIA
Official FDA Label for ATROPINE\DIPHENOXYLATE
Official prescribing information from the FDA-approved drug label.